TEVA Pharmaceuticals sells Forest facility to private investor | WSET
Teva Pharmaceuticals Portfolio Investments, Teva Pharmaceuticals Funds, Teva Pharmaceuticals Exits
Here's Why Teva Shares are Trending Higher Today - TipRanks.com
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharmaceutical Industries Adds US$389m To Market Cap, But Investors Still Down 47% From Five Years Ago - Simply Wall St News
Teva Reports Earnings Tomorrow. Here's What to Expect. | Barron's
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
NuPathe acquired by Teva for $144M - Technical.ly
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva Selling $3.5 Billion of Junk Bonds to Refinance Debt - Bloomberg
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Why the Teva Pharmaceuticals Stock Rebound May Be Real | InvestorPlace
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva Pharmaceuticals will pay $420 million in a federal case
Jewish Values Investors JLens Target Israeli Company
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Stock Price Today | NYSE TEVA Live Ticker - Investing.com
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
